Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- bs-12359R - Provider product page
- Provider
- Bioss
- Product name
- DMP1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Description
- KLH conjugated synthetic peptide derived from human DMP1
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100ul
- Concentration
- 1ug/ul
- Storage
- Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for 12 months.
Submitted references Aqueous extract from You-Gui-Yin ameliorates cognitive impairment of chronic renal failure mice through targeting hippocampal CaMKIIα/CREB/BDNF and EPO/EPOR pathways.
The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
A novel three-dimensional culture system maintaining the physiological extracellular matrix of fibrotic model livers accelerates progression of hepatocellular carcinoma cells.
Tang Q, Ke H, Wu C, Zeng J, Li Z, Liu Y, Feng S, Xue Q, Xu X
Journal of ethnopharmacology 2019 Jul 15;239:111925
Journal of ethnopharmacology 2019 Jul 15;239:111925
The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
Lin Y, Ma Q, Li L, Wang H
Biochemistry and cell biology = Biochimie et biologie cellulaire 2018 Oct;96(5):619-626
Biochemistry and cell biology = Biochimie et biologie cellulaire 2018 Oct;96(5):619-626
A novel three-dimensional culture system maintaining the physiological extracellular matrix of fibrotic model livers accelerates progression of hepatocellular carcinoma cells.
Miyauchi Y, Yasuchika K, Fukumitsu K, Ishii T, Ogiso S, Minami T, Kojima H, Yamaoka R, Katayama H, Kawai T, Yoshitoshi-Uebayashi EY, Kita S, Yasuda K, Sasaki N, Uemoto S
Scientific reports 2017 Aug 29;7(1):9827
Scientific reports 2017 Aug 29;7(1):9827
No comments: Submit comment
No validations: Submit validation data